180 related articles for article (PubMed ID: 36897459)
1. Efficacy and safety of picosecond laser for the treatment of melasma: a systematic review and meta-analysis.
Feng J; Shen S; Song X; Xiang W
Lasers Med Sci; 2023 Mar; 38(1):84. PubMed ID: 36897459
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.
Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS
Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574
[TBL] [Abstract][Full Text] [Related]
3. Laser therapy in the treatment of melasma: a systematic review and meta-analysis.
Lai D; Zhou S; Cheng S; Liu H; Cui Y
Lasers Med Sci; 2022 Jun; 37(4):2099-2110. PubMed ID: 35122202
[TBL] [Abstract][Full Text] [Related]
4. Fractional 1064 nm Picosecond Laser in Treatment of Melasma and Skin Rejuvenation in Asians, A Prospective Study.
Wong CSM; Chan MWM; Shek SYN; Yeung CK; Chan HHL
Lasers Surg Med; 2021 Oct; 53(8):1032-1042. PubMed ID: 33544930
[TBL] [Abstract][Full Text] [Related]
5. The role of 755-nm alexandrite picosecond laser in melasma management.
Pulumati A; Jaalouk D; Algarin YA; Nouri K
Arch Dermatol Res; 2023 Dec; 316(1):60. PubMed ID: 38151661
[TBL] [Abstract][Full Text] [Related]
6. Combination of a 755-nm picosecond laser and hydroquinone 2% cream versus hydroquinone 2% cream alone for the treatment of melasma: A randomized, split-face, and controlled trial.
Manuskiatti W; Yan C; Gulfan MCB; Techapichetvanich T; Wanitphakdeedecha R
Lasers Surg Med; 2022 Dec; 54(10):1245-1250. PubMed ID: 36345697
[TBL] [Abstract][Full Text] [Related]
7. 755-nm picosecond laser plus topical 20% azelaic acid compared to topical 20% azelaic acid alone for the treatment of melasma: a randomized, split-face and controlled trial.
Lai D; Cheng S; Zhou S; Hao J; Chen H; Jia K; Liu H; Cui Y
Lasers Med Sci; 2024 Apr; 39(1):113. PubMed ID: 38656631
[TBL] [Abstract][Full Text] [Related]
8. Single and combined 1064 nm Q-switched Nd: YAG laser therapy in melasma: A meta-analysis.
Zhang B; Xie B; Shen Y; Zhang L; Song X
J Cosmet Dermatol; 2022 Sep; 21(9):3794-3802. PubMed ID: 35876484
[TBL] [Abstract][Full Text] [Related]
9. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
Ustuner P; Balevi A; Ozdemir M
J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
[TBL] [Abstract][Full Text] [Related]
10. Effects of a fractional picosecond 1,064 nm laser for the treatment of dermal and mixed type melasma.
Chalermchai T; Rummaneethorn P
J Cosmet Laser Ther; 2018 Jun; 20(3):134-139. PubMed ID: 29020467
[TBL] [Abstract][Full Text] [Related]
11. Melasma treatment with a 1064 nm, picosecond-domain laser with a fractionated multibeam lens array.
Bernstein EF; Basilavecchio LD; Wang J
Lasers Surg Med; 2023 Nov; 55(9):801-808. PubMed ID: 37668307
[TBL] [Abstract][Full Text] [Related]
12. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians.
Wattanakrai P; Mornchan R; Eimpunth S
Dermatol Surg; 2010; 36(1):76-87. PubMed ID: 20298254
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Picosecond Laser in the Treatment of Melasma: A Network Meta-analysis.
Ren R; Bao S; Qian W; Zhao H
Dermatol Surg; 2023 May; 49(5S):S49-S55. PubMed ID: 37116000
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety Evaluation of Picosecond Alexandrite Laser with a Diffractive Lens Array for Treatment of Melasma in Asian Patients by VISIA Imaging System.
Chen YT; Lin ET; Chang CC; Lin BS; Chiang HM; Huang YH; Lin HY; Wang KY; Chang TM
Photobiomodul Photomed Laser Surg; 2019 Sep; 37(9):559-566. PubMed ID: 31411549
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of laser-assisted delivery of tranexamic acid for the treatment of melasma: a systematic review and meta‑analysis.
Feng J; Shen S; Song X; Xiang W
J Cosmet Laser Ther; 2022 Nov; 24(6-8):73-79. PubMed ID: 36403155
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the efficacy and safety of picosecond Nd:YAG laser (1,064 nm), picosecond alexandrite laser (755 nm) and 2% hydroquinone cream in the treatment of melasma: A randomized, controlled, assessor-blinded trial.
Liang S; Shang S; Zhang W; Tan A; Zhou B; Mei X; Li L
Front Med (Lausanne); 2023; 10():1132823. PubMed ID: 37056729
[TBL] [Abstract][Full Text] [Related]
17. A prospective, split-face study comparing 1,064-nm picosecond Nd:YAG laser toning with 1,064-nm Q-switched Nd:YAG laser toning in the treatment of melasma.
Hong JK; Shin SH; Park SJ; Seo SJ; Park KY
J Dermatolog Treat; 2022 Aug; 33(5):2547-2553. PubMed ID: 35067157
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Topical Silymarin Versus Low Fluence 1064-nm Q Switched Nd:YAG Laser in the Treatment of Melasma: A Comparative Randomized Trial.
Ibrahim SMA; Farag AS; Ali MS; El-Gendy WMAF
Lasers Surg Med; 2021 Dec; 53(10):1341-1347. PubMed ID: 34101206
[TBL] [Abstract][Full Text] [Related]
19. A Prospective, Split-Face, Randomized Study Comparing a 755-nm Picosecond Laser With and Without Diffractive Lens Array in the Treatment of Melasma in Asians.
Manuskiatti W; Yan C; Tantrapornpong P; Cembrano KAG; Techapichetvanich T; Wanitphakdeedecha R
Lasers Surg Med; 2021 Jan; 53(1):95-103. PubMed ID: 32865858
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of laser and topical tranexamic acid combination therapy in melasma: An updated systematic review and meta-analysis of randomized controlled trials.
Khan QA; Abdi P; Farkouh C; Anthony MR; Chundru A; Amatul F; Parimi K; Santiago N; Farkouh M; Iram S; Khan A
Lasers Med Sci; 2023 Jun; 38(1):139. PubMed ID: 37326860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
